Erratum

Erratum

Utine CA. Update and critical appraisal of the use of topical azithromycin ophthalmic 1% (AzaSite®) solution in the treatment of ocular infections. Clin Ophthalmol. 2011;5:801-809.Table 2 inaccurately states that Bremond-Grignac used AzaSite® in their study. The ophthalmic pr...

Full description

Bibliographic Details
Main Author: Utine CA
Format: Article
Language:English
Published: Dove Medical Press 2011-09-01
Series:Clinical Ophthalmology
Online Access:http://www.dovepress.com/erratum---a8378
id doaj-7252bc8ebd5d4de4aed1e7477b4e0843
record_format Article
spelling doaj-7252bc8ebd5d4de4aed1e7477b4e08432020-11-25T01:20:28ZengDove Medical PressClinical Ophthalmology1177-54671177-54832011-09-012011default14151416ErratumUtine CAUtine CA. Update and critical appraisal of the use of topical azithromycin ophthalmic 1% (AzaSite®) solution in the treatment of ocular infections. Clin Ophthalmol. 2011;5:801-809.Table 2 inaccurately states that Bremond-Grignac used AzaSite® in their study. The ophthalmic preparation used was in fact Azyter®. Original Articlehttp://www.dovepress.com/erratum---a8378
collection DOAJ
language English
format Article
sources DOAJ
author Utine CA
spellingShingle Utine CA
Erratum
Clinical Ophthalmology
author_facet Utine CA
author_sort Utine CA
title Erratum
title_short Erratum
title_full Erratum
title_fullStr Erratum
title_full_unstemmed Erratum
title_sort erratum
publisher Dove Medical Press
series Clinical Ophthalmology
issn 1177-5467
1177-5483
publishDate 2011-09-01
description Utine CA. Update and critical appraisal of the use of topical azithromycin ophthalmic 1% (AzaSite®) solution in the treatment of ocular infections. Clin Ophthalmol. 2011;5:801-809.Table 2 inaccurately states that Bremond-Grignac used AzaSite® in their study. The ophthalmic preparation used was in fact Azyter®. Original Article
url http://www.dovepress.com/erratum---a8378
work_keys_str_mv AT utineca erratum
_version_ 1725133974802530304

Similar Items